Skip to main content
. 2016 Oct 13;66(1):170–176. doi: 10.2337/db16-0754

Table 2.

Results from multivariate logistic models testing the association between τPCr (s) and likelihood (odds ratio) of having prediabetes or being in a higher tertile of HOMA index, Matsuda index, and reduced Matsuda index

Likelihood of prediabetes
Model I (age, sex, and %PCr depletion adjusted) (N = 248) Model II* (N = 248) Model III§ (N = 248)
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
τPCr (s) 1.05 (1.03–1.08) <0.001 1.06 (1.02–1.09) <0.001 1.06 (1.03–1.10) <0.001
Model IV (N = 247) Model V# (N = 248) Model VI** (N = 248) Model VII (N = 248)
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
τPCr (s) 1.07 (1.03–1.10) <0.001 1.06 (1.03–1.09) <0.001 1.05 (1.02–1.09) <0.001 1.06 (1.03–1.09) <0.001
Higher tertile of HOMA index (IR)
Model I (age, sex, and %PCr depletion adjusted) (N = 248) Model II* (N = 248) Model III§ (N = 248)
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
τPCr (s) 1.04 (1.01–1.06) 0.002 1.04 (1.01–1.07) 0.002 1.04 (1.01–1.07) 0.003
Model IV (N = 247) Model V# (N = 248) Model VI** (N = 248) Model VII (N = 248)
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
τPCr (s) 1.05 (1.02–1.08) 0.001 1.04 (1.01–1.07) 0.003 1.03 (1.01–1.06) 0.015 1.05 (1.02–1.08) 0.001
Higher tertile of Matsuda index (insulin sensitivity)
Model I (age, sex, and %PCr depletion adjusted) (N = 248) Model II* (N = 248) Model III§ (N = 248)
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
τPCr (s) 0.96 (0.94–0.98) 0.001 0.96 (0.93–0.99) 0.004 0.96 (0.93–0.99) 0.003
Model IV (N = 247) Model V# (N = 248) Model VI** (N = 248) Model VII (N = 248)
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
τPCr (s) 0.95 (0.92–0.98) 0.001 0.96 (0.93–0.98) 0.003 0.97 (0.94–0.99) 0.011 0.95 (0.93–0.98) 0.001
Higher tertile of reduced Matsuda index (insulin sensitivity)
Model I (age, sex, and %PCr depletion adjusted) (N = 248) Model II* (N = 248) Model III§ (N = 248)
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
τPCr (s) 0.95 (0.93–0.97) <0.001 0.95 (0.92–0.98) <0.001 0.95 (0.92–0.98) <0.001
Model IV (N = 247) Model V# (N = 248) Model VI** (N = 248) Model VII (N = 248)
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
τPCr (s) 0.94 (0.92–0.97) <0.001 0.95 (0.92–0.98) <0.001 0.96 (0.93–0.98) 0.001 0.95 (0.92–0.97) <0.001

OR, odds ratio.

*Age, sex, %PCr depletion, race, education, smoking status, physical activity level, body weight, body height, and DEXA-measured trunk FM.

§Age, sex, %PCr depletion, race, education, smoking status, physical activity level, body weight, body height, DEXA-measured trunk FM, and plasma levels of IL-6, CRP, leptin, and adiponectin.

†Age, sex, %PCr depletion, race, education, smoking status, physical activity level, body height, body weight, waist circumference, and plasma levels of IL-6, CRP, leptin, and adiponectin.

#Age, sex, %PCr depletion, race, education, smoking status, physical activity level, body weight, body height, DEXA-measured TBFM, and plasma levels of IL-6, CRP, leptin, and adiponectin.

**Age, sex, %PCr depletion, race, education, smoking status, physical activity level, body height, percentage of body fatness, and plasma levels of IL-6, CRP, leptin, and adiponectin.

‡Age, sex, %PCr depletion, race, education, smoking status, physical activity level, BMI, and plasma levels of IL-6, CRP, leptin, and adiponectin.